Coronavirus, COVID, Newborn and Infant Health, Pregnancy, Vaccines

COVID-19 vaccination and boosting during pregnancy benefits pregnant people and newborns

The researchers found that pregnant women who received the COVID-19 vaccines generated antibodies against specific types of SARS-CoV-2. These antibodies crossed the placenta and were also found in the cord blood of vaccinated participants. This likely conferred some protection in the newborns against infection immediately after birth—a critical time when they are vulnerable to severe COVID-19 disease but are too young to be vaccinated.

Blood Pressure

What is POTS? And how is it related to long COVID?

POTS or “postural orthostatic tachycardia syndrome” is a poorly recognised condition we’ve been hearing more about recently. Before COVID, this debilitating condition was not widely talked about. But during the pandemic, we’ve been learning about the strong similarities with long COVID.

End-of-Life Care, Pain Medicine, Palliative Care

What actually is palliative care? And how is it different to end-of-life care?

Palliative care is not voluntary assisted dying. It does not aim to hasten or prolong death. It is not just for people who are about to die and seeking palliative care does not mean “giving up”. In fact, it can be a profound and positive form of care that the World Health Organization (WHO) has recognised as a basic human right. But what does it involve?

Cancer, Drugs, Vaccines

Immune cells that fight cancer become exhausted within hours of first encountering tumors – new research

A type of T cell called cytotoxic T cells can recognize the mutated proteins on cancer cells and should therefore be able to kill them. However, in most patients, cancer cells grow unchecked despite the presence of T cells.

The current explanation scientists have as to why T cells fail to eliminate cancer cells is because they become “exhausted.” The idea is that T cells initially function well when they first face off against cancer cells, but gradually lose their ability to kill the cancer cells after repeated encounters.